What nutrients can help protect blood vessels and increase vascular elasticity, and are there any specific considerations for individuals with certain medical conditions, such as cardiovascular disease, kidney disease, or diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

保護血管與增加血管彈性的營養品建議

根據美國心臟協會指南，每日攝取25克大豆蛋白（含異黃酮）可改善血脂並增強血管彈性，而Omega-3脂肪酸（EPA+DHA每日0.5-1.8克）則可降低心血管死亡率並改善內皮功能。1

主要推薦營養品

1. 大豆蛋白與異黃酮

  • 每日建議攝取量：25-50克大豆蛋白（需含完整異黃酮成分）1

  • 血管保護機制：

    • 異黃酮可改善動脈順應性（arterial compliance），直接作用於血管系統1
    • 增強血管反應性（vascular reactivity），獨立於血脂代謝之外1
    • 抑制酪氨酸激酶（tyrosine kinase），減少血栓和動脈斑塊形成1
    • 作為抗氧化劑，抑制低密度脂蛋白氧化1
    • 降低低密度脂蛋白膽固醇，提高高密度脂蛋白膽固醇1

  • 重要注意事項： 單獨補充異黃酮萃取物（不含大豆蛋白）雖可改善血管彈性，但無法降低膽固醇；需要大豆蛋白與異黃酮共同作用才能達到最大心血管保護效果1

2. Omega-3脂肪酸（EPA與DHA）

  • 每日建議攝取量：

    • 一般心血管保護：0.5-1.8克EPA+DHA（每週至少兩次富含脂肪的魚類）1
    • 已確診冠心病患者：1克EPA+DHA1
    • 高三酸甘油酯血症：2-4克（需醫師監督）1

  • 血管保護機制：

    • 改善內皮功能（endothelial function）1, 2
    • 降低血壓（輕微但有效）1
    • 減少血栓形成風險1
    • 減緩動脈粥狀硬化斑塊生長速度1
    • 降低發炎反應1
    • 在第二型糖尿病和血脂異常患者中改善動脈順應性3

  • 食物來源： 鯖魚、鮭魚、鯡魚、沙丁魚、鮪魚1

3. 鉀（Potassium）

  • 每日建議攝取量：約110 mmol/day（約4,300毫克）1

  • 血管保護機制：

    • 降低血壓，尤其在高血壓患者和高鈉攝取時效果更顯著1
    • 降低中風風險達40%（最高與最低攝取量五分位數比較）1
    • 減弱鈉對血壓的升高效應1

  • 食物來源： 蔬菜、水果、全穀物、豆類、堅果1

4. 維生素C

  • 每日建議攝取量：200-500毫克用於代謝症候群預防4

  • 血管保護機制：

    • 降低收縮壓和舒張壓（中位數攝取量500毫克時效果顯著）4
    • 降低總膽固醇和低密度脂蛋白膽固醇4
    • 改善血糖控制4
    • 作為抗氧化劑，恢復內皮功能1

  • 安全上限： 成人每日2,000毫克4

5. 多酚類化合物（Polyphenols）

  • 有效來源： 黑巧克力（每日6.3克/30大卡）、茶、紅酒、葡萄、莓果1, 2
  • 血管保護機制：
    • 降低血壓1
    • 改善內皮功能1, 2
    • 改善胰島素抗性1
    • 增加內皮一氧化氮生成1

不建議或需謹慎使用的營養品

維生素E

  • 不建議用於血管保護： 大型隨機對照試驗顯示維生素E對心血管事件（心肌梗塞、中風、血管性死亡）無益處1
  • 對間歇性跛行（intermittent claudication）無效1

銀杏（Ginkgo Biloba）

  • 效果有限： 雖可改善疼痛性行走距離34米，但臨床意義不大1
  • 缺乏大型高品質研究支持1

鈣和鎂補充劑

  • 不建議用於心血管預防： 鈣補充劑可能顯著增加心肌梗塞風險1
  • 鎂補充劑雖可輕微降低血壓，但長期試驗尚未完成1

禁忌症與特殊族群注意事項

大豆蛋白

  • 相對安全： 每日25-50克大豆蛋白已證實安全1
  • 無特定禁忌症記載於指南中

Omega-3脂肪酸

  • 需醫師監督情況： 每日超過3克可能導致某些人過度出血1
  • 孕婦和兒童： 應避免高汞魚類，選擇低汞且富含Omega-3的魚類1
  • 魚油補充劑不含汞1

維生素C

  • 禁忌症：4
    • 血色素沉著症（hemochromatosis）患者
    • 葡萄糖-6-磷酸去氫酶缺乏症（G6PD deficiency）患者
    • 草酸鹽結石形成風險者

鉀補充劑

  • 腎臟疾病患者需謹慎： 慢性腎臟病患者可能無法有效排泄鉀，導致高血鉀症5
  • 使用保鉀利尿劑或血管收縮素轉化酶抑制劑的患者需監測血鉀5

臨床應用建議

優先順序：

  1. 首選透過天然食物攝取（大豆製品、富含脂肪的魚類、蔬果）1
  2. 已確診心血管疾病患者可考慮Omega-3補充劑（1克/天）1
  3. 高膽固醇患者可增加大豆蛋白攝取至25克/天1
  4. 高血壓患者應增加鉀攝取並限制鈉攝取1

重要提醒： 這些營養品的益處需要長期持續攝取才能維持，一旦恢復低攝取量，保護效果會消失4。食物來源與補充劑的生物利用度相當，但食物來源提供額外的纖維和複合碳水化合物，對代謝症候群有獨立益處4。

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

4
Guideline

Vitamin C Intake and Metabolic Syndrome Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5
Research

Cardiovascular disease and its relationship with chronic kidney disease.

European review for medical and pharmacological sciences, 2014

Related Questions

What is the best management approach for an adult patient with stage 4 chronic kidney disease, anemia, hyperglycemia, hyperkalemia, dyslipidemia, and possible heart failure?
What is the approach to a patient with bipedal edema, particularly those with a history of cardiovascular disease, hypertension, or diabetes, to consider chronic kidney disease (CKD) as a potential underlying cause?
What are the primary causes of death in patients with Chronic Kidney Disease (CKD)?
What is the best management approach for an elderly patient with a history of multiple cerebrovascular accidents, carotid artery stenosis, chronic kidney disease, coronary artery disease, chronic diastolic heart failure, hypertension, and hyperlipidemia, who presents with acute metabolic encephalopathy and hyponatremia, and has generalized weakness and mobility issues?
What is the most common cause of death in a patient with Chronic Kidney Disease (CKD)?
What is the recommended use of renal dose dopamine in patients with acute kidney injury or impaired renal function, considering their medical history and potential comorbidities such as hypertension, diabetes, or cardiovascular disease?
Can I give telmisartan (Angiotensin II Receptor Blocker) 40 mg to a non-hypertensive diabetic patient with proteinuria and hematuria?
What is the recommended treatment for a patient with a suspected MRSA (Methicillin-resistant Staphylococcus aureus) infection?
What is the best course of action for a diabetic patient with hematuria, proteinuria, and normal creatinine levels?
What is the recommended long-term therapy for a patient with chronic obstructive pulmonary disease (COPD) and a history of exacerbations or severe airflow limitation, using inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combinations?
What is the treatment for a patient with Runs of Ventricular Oversensing Tachycardia (Rvot) and Ventricular Premature Complexes (VPCs)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question